{"title":"Treatment Outcome of Flow Diverter Device for Medium-Sized Cerebral Aneurysms: A Single-Center Report.","authors":"Saya Ozaki, Hirotoshi Imamura, Akihiro Niwa, Taishi Tsutsui, Naoto Yamada, Taichi Ikedo, Eika Hamano, Kiyofumi Yamada, Hisae Mori, Koji Iihara, Hiroharu Kataoka","doi":"10.5797/jnet.oa.2024-0025","DOIUrl":"10.5797/jnet.oa.2024-0025","url":null,"abstract":"<p><strong>Objective: </strong>Flow diverters (FDs), first introduced in Japan in 2015, were initially limited to wide-necked large cerebral aneurysms, which pose a high treatment risk. However, based on the results of the PREMIER study, the indications have expanded since 2020, and the number of treatment cases is increasing in Japan. At our hospital, FD placement with adjunctive coil embolization has been actively performed for medium-sized cerebral aneurysms, as indicated in the PREMIER study; herein, we report the outcomes of this treatment.</p><p><strong>Methods: </strong>Of the 25 patients with 28 aneurysms who underwent FD placement at our institution between April 2022 and June 2023, 15 with 17 wide-necked unruptured cerebral aneurysms with a maximum diameter of <12 mm in the internal carotid artery (ICA) or vertebral artery (VA) were included. Postoperative complications were investigated in each case, and the aneurysm occlusion status was assessed using ultrashort echo time (UTE)-MRA at 3 months postoperatively and angiography at 6 months postoperatively. Fifteen patients who underwent coiling or stent-assisted coiling (SAC) for the same criteria during the same period were compared. Baseline characteristics and treatment results were compared between FD and coiling/SAC cases.</p><p><strong>Results: </strong>Four males and 11 females with a mean age of 61.7 ± 12.8 years were included, and the median follow-up period was 9 months (6-18 months). There were 14 aneurysms of the ICA and 3 of the VA, and the mean maximum aneurysm diameter was 7.9 ± 1.7 mm. All patients were treated using the Pipeline Flex with Shield Technology (Medtronic, Minneapolis, MN, USA), and 14 aneurysms (82.4%) were treated with adjunctive coil embolization. There were no symptomatic strokes in the perioperative period; only one patient receiving corticosteroid therapy for thyroid eye disease had asymptomatic ICA occlusion at 3 months. Fifteen aneurysms (88.2%) were not visible on UTE-MRA at 3 months postoperatively, and angiography at 6 months showed complete occlusion in 16 (94.1%) aneurysms. The coiling/SAC group had a smaller neck size and higher volume embolization ratio than the FD group; however, complete occlusion was higher in the FD group.</p><p><strong>Conclusion: </strong>FD placement with adjunctive coil embolization for medium-sized cerebral aneurysms is expected to result in good occlusion rates in the early postoperative period.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 9","pages":"231-239"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11412774/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Safety and Risk Factors of Carotid Artery Stenting with Simple Distal Filter Protection: A Single-Center Retrospective Study.","authors":"Wataru Shimohigoshi, Taisuke Akimoto, So Ozaki, Shuto Fushimi, Ryosuke Takagi, Takafumi Kawasaki, Koichi Uramaru, Junya Tatezuki, Hiroshi Manaka, Yasunobu Nakai, Katsumi Sakata, Tetsuya Yamamoto","doi":"10.5797/jnet.oa.2023-0096","DOIUrl":"10.5797/jnet.oa.2023-0096","url":null,"abstract":"<p><strong>Objective: </strong>Carotid artery stenting embolic protection devices offer various options, among which distal filter protection is the simplest and easiest to handle. However, compared to balloon protection systems, distal filter protection has more embolic complications. Therefore, we explored the risk factors of distal filter protection, intending to achieve a safer carotid artery stenting. This retrospective study was conducted to identify prognostic factors following carotid artery stenting with only distal filter protection from July 2010 to June 2021.</p><p><strong>Methods: </strong>Information on patient background, procedures and devices, and complications was collected using medical records. The data pertaining to 187 patients were analyzed after excluding the data of patients in whom other protection devices (8 cases) were used. We used FilterWire EZ as the first choice for embolic protection device and SpiderFX when the patients had difficult-to-cross lesions.</p><p><strong>Results: </strong>The patients' mean age was 71.9 ± 6.9 years, and 72 (38.5%) were symptomatic. Symptomatic (odds ratio: 2.02, p = 0.035) and difficult-to-cross lesions (odds ratio: 3.63, p = 0.0013) were factors independently associated with symptomatic complications.</p><p><strong>Conclusion: </strong>This retrospective single-center study established independent prognostic factors for carotid artery stenting with distal filter protection. For patients with symptomatic lesions and severe stenosis or bends that are difficult to pass through, it is necessary to be careful when performing carotid artery stenting with distal filter protection.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 6","pages":"155-163"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11189783/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Systemic Embolism Following Mechanical Thrombectomy for Acute Ischemic Stroke: A Case of Suspected Catastrophic Antiphospholipid Syndrome.","authors":"Ryutaro Makino, Akari Machida, Yushi Nagano, Shunichi Tanaka, Ayumi Taniguchi, Ryosuke Hanaya","doi":"10.5797/jnet.cr.2024-0023","DOIUrl":"10.5797/jnet.cr.2024-0023","url":null,"abstract":"<p><strong>Objective: </strong>Catastrophic antiphospholipid syndrome (CAPS) is a disease characterized by a poor prognosis and a high mortality rate, leading to systemic thrombosis. Approximately two-thirds of CAPS cases are associated with conditions such as infections, malignancies, surgical interventions, and events linked to the disease activity of systemic lupus erythematosus (SLE). Herein, we present a case of CAPS with multiorgan ischemia following ischemic stroke.</p><p><strong>Case presentation: </strong>In this case report, a 33-year-old woman with a history of SLE and prolonged steroid use manifested impaired consciousness. Detection of the right internal carotid artery (ICA) occlusion led to successful ICA recanalization through endovascular thrombectomy. Postoperatively, she experienced pulmonary embolism and renal infarction. Although antiphospholipid syndrome (APS) was suspected, APS-related antibodies were negative. Anticoagulation therapy was initiated, presuming corticosteroid-induced thrombosis. However, she developed multiorgan thrombosis, culminating in multiple organ failure. Based on her clinical course, a diagnosis of CAPS was established. Intensive care and plasma exchange therapy were instrumental in her recovery, and she was discharged with a modified Rankin Scale score of 4.</p><p><strong>Conclusion: </strong>When encountering multiorgan ischemia following ischemic stroke in a young adult patient with an autoimmune disease, the consideration of CAPS as a differential diagnosis is crucial, even if APS-related antibodies test negative.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 7","pages":"197-202"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11260516/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141749870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical Impact of a Local Triage System Using the Emergent Large Vessel Occlusion Screen with a Rotation System of Thrombectomy-Capable Hospitals.","authors":"Yusuke Takahashi, Takahiro Ono, Junta Moroi, Jun Maruya, Shuntaro Togashi, Takatsugu Abe, Hajime Nakae, Yasuo Fujita, Shinichi Takahashi, Hiroaki Shimizu","doi":"10.5797/jnet.oa.2023-0097","DOIUrl":"10.5797/jnet.oa.2023-0097","url":null,"abstract":"<p><strong>Objective: </strong>Early intervention with mechanical thrombectomy (MT) is expected to improve the functional outcome in patients with large vessel occlusion (LVO); however, a method for the effective detection of these patients in a prehospital setting and early transport to MT-capable hospitals has not been established. This study aimed to analyze the clinical impact and diagnostic performance of the emergent large vessel occlusion (ELVO) screen and its influence on the transportation time.</p><p><strong>Methods: </strong>The emergency medical services (EMS) in one of the secondary medical areas in Akita, Japan, introduced a prehospital triage system employing an ELVO screen and a rotation system of three MT-capable hospitals on December 1, 2021. Patients who were transferred to each of the three hospitals involved in the rotation system according to a predefined priority list from December 2021 to November 2022 were included in the triage group. Patients who underwent MT in the three hospitals before the introduction of the triage system were assigned to the pre-triage group. We compared the transportation time parameters between the two groups and analyzed the performance of the ELVO screen for the diagnosis of LVOs. This study was approved by the institutional review boards of all three hospitals.</p><p><strong>Results: </strong>Time parameters were compared between the 37 and 42 patients who underwent MT and had detailed data in the triage (n = 351) and pre-triage (n = 43) groups, respectively. The time from door to puncture tended to decrease in the triage group in all hospitals, with one hospital showing a statistically significant shortening of 14 min (p = 0.018). In the triage group, 209 ELVO screen-positive patients were present, with 60 (28.7%) of these having LVO. The sensitivity, specificity, positive and negative predictive values, and area under the curve of the ELVO screen to detect LVO under the present triage system were 87.0%, 47.2%, 28.7%, 93.7%, and 0.671, respectively.</p><p><strong>Conclusion: </strong>The present study demonstrated that the introduction of a triage system may have shortened the time required for MT. ELVO screen may be considered a useful marker for screening LVO in prehospital settings in terms of the sensitivity and negative predictive value; however, further improvement may be necessary to reduce the rate of false positive results.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 4","pages":"103-109"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11076143/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140893035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical Features of Intracranial Dural Arteriovenous Fistulas with Spinal Perimedullary Venous Drainage: Report of Two Cases and Literature Review.","authors":"Katsuya Saito, Go Ikeda, Yoshimitsu Akutsu, Yusuke Morinaga, Shunsuke Kawamoto, Hiroyoshi Akutsu","doi":"10.5797/jnet.cr.2024-0015","DOIUrl":"10.5797/jnet.cr.2024-0015","url":null,"abstract":"<p><strong>Objective: </strong>We describe two cases of myelopathy onset due to intracranial dural arteriovenous fistulas (DAVFs) and present a literature review.</p><p><strong>Case presentation: </strong>(Case 1) A 44-year-old man with subacute onset myelopathy underwent an MRI and DSA. MRI showed T2-hyperintensity from the medulla oblongata to the cervical spinal cord with vascular flow voids, suggestive of a spinal DAVF. Unexpectedly, cerebral angiography revealed a tentorial DAVF. (Case 2) A 47-year-old man with progressive myelopathy underwent a head and spinal MRI. Head MRI and MRA were considered to be normal. Spinal MRI revealed T2-hyperintensity in the cervical spinal cord without obvious vascular flow voids around the spinal cord. Contrast-enhanced MRI showed a patchy gadolinium enhancement in the same spinal cord region with the enhancement of perimedullary vessels. Although myelitis was initially suspected, subsequently spinal DAVF was suspected because cervical CTA revealed abnormal spinal venous drainage. Unexpectedly, cerebral angiography identified a foramen magnum DAVF.</p><p><strong>Conclusion: </strong>Regarding unexplained cervical myelopathy, even the absence of spinal cord surface vascular flow voids cannot necessarily exclude venous congestive myelopathy due to the DAVFs. In such cases, the contrast-enhanced MRI and cervical CTA are useful for visualizing abnormal vessels around the brain stem and the cervical spine. Especially, the co-presence of the abnormal vessels around the brain stem can suggest the intracranial DAVFs. Not only spinal DAVFs but also intracranial DAVFs should be considered as the differential diagnoses for venous congestive cervical myelopathy, in which cases cerebral angiography including carotid angiography is essential.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 11","pages":"298-304"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142683704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Delayed Stent Infection after Deployment of a Carotid Dual Layer Stent in Dialysis Cases.","authors":"Tetsuya Ioku, Keisuke Imai, Takehiro Yamada, Masanori Cho, Toshi Sai, Takuma Kato","doi":"10.5797/jnet.cr.2023-0081","DOIUrl":"10.5797/jnet.cr.2023-0081","url":null,"abstract":"<p><strong>Objective: </strong>Infection after carotid artery stenting (CAS) is rare. We report two dialysis cases of delayed stent infection associated with a carotid dual-layer stent (DLS), which occurred several months after deployment of the stent.</p><p><strong>Case presentations: </strong><i>Case 1</i>: A 74-year-old man receiving dialysis underwent CAS with DLS. Three months after CAS, the patient developed a high fever, neck pain, and neck swelling. Neck CT and carotid ultrasonography (CUS) indicated an abscess around the inserted DLS. The patient was treated with antibiotic agents and fully recovered. <i>Case 2</i>: A 73-year-old man receiving dialysis underwent CAS with DLS. Two months after CAS, this patient also developed a high fever, neck pain, and neck swelling. Contrast-enhanced neck CT indicated inflammatory effusion with an abscess and a giant infectious pseudoaneurysm. Endovascular stent graft reconstruction was employed urgently under antibiotic therapy to prevent its rupture. However, intracranial hemorrhage occurred postoperatively and left hemiparesis remained.</p><p><strong>Conclusion: </strong>Delayed carotid stent infection is a rare but severe complication. The use of a DLS might be avoided during CAS for dialysis cases.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 4","pages":"126-129"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11076145/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140893039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Comparison and Evaluation of Two Commercially Available Metal Artifact Reduction Applications.","authors":"Mitsuharu Osawa, Naotoshi Fujita, Shuji Koyama, Naoki Kaneda, Shigeru Miyachi","doi":"10.5797/jnet.oa.2023-0095","DOIUrl":"10.5797/jnet.oa.2023-0095","url":null,"abstract":"<p><strong>Objective: </strong>The angiography systems A (A) and B (B), both incorporated at our hospital, are equipped with metal artifact reduction (MAR) applications. In clinical practice, it is crucial to understand the characteristics of MAR in both systems given that endovascular treatments are occasionally administered with both. In this study, we compared the artifact reduction effects of MAR on equipment A and B and clarified the differences between the two systems.</p><p><strong>Methods: </strong>An artifact evaluation phantom was created using a cylindrical water phantom and an iodine contrast medium. The phantom was imaged, MAR processing was performed on the obtained images, and an isotropic quantitative evaluation of artifacts was performed by extreme value statistical analysis using the Gumbel distribution.</p><p><strong>Results: </strong>The MAR reduction effects were approximately 45% and 40% for equipment A and B at concentrations of 8300 and 6000, respectively. The MAR reduction effect in both devices exhibited different trends depending on the concentration.</p><p><strong>Conclusion: </strong>In clinical procedures that make use of absorbents in medium concentrations of approximately 3000-5000, such as n-butyl-2-cyanoacrylate and Onyx, it is necessary to understand the MAR characteristics of both devices and consider the use of alternative devices as an option.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 8","pages":"213-218"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11333156/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142010053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"First Experience with Endovascular Treatment of Cerebral Aneurysms Using Sub-Marker Catheter.","authors":"Hideaki Shigematsu, Azusa Sunaga, Takuya Yonemochi, Akihiro Hirayama, Takatoshi Sorimachi, Masamichi Takahashi","doi":"10.5797/jnet.oa.2024-0050","DOIUrl":"10.5797/jnet.oa.2024-0050","url":null,"abstract":"<p><strong>Objective: </strong>Prehension of the position of the microcatheter tip under fluoroscopy during cerebral aneurysm embolization is critical to prevent intraoperative rupture of the aneurysm, even if the first marker at the tip is obscured by coils in the aneurysm. This study presents our initial experience with a sub-marker catheter, which includes an additional marker positioned 5 mm from the tip, designed to facilitate accurate positioning of the microcatheter tip.</p><p><strong>Methods: </strong>We analyzed cases of cerebral aneurysms treated with sub-marker catheters at our hospital from July 2022 to September 2023. Single catheter embolization served as the primary treatment option, with balloon-assisted or stent-assisted techniques utilized only when necessary.</p><p><strong>Results: </strong>During the study period, 18 patients with cerebral aneurysms were treated using sub-marker catheters. The median age of these patients was 65 years, comprising 8 men and 10 women. The aneurysms had a median maximum diameter of 6.2 mm, ranging from 5.0 to 16.8 mm. Among the 18 treated patients, 14 had unruptured aneurysms and 4 had ruptured aneurysms. Treatment methods included single catheter embolization in 10 patients, double catheter embolization in 3, stent-assisted embolization in 3, balloon-assisted embolization in 1, and flow diverter placement combined with coil embolization in 1. The sub-marker was consistently visible under fluoroscopy, aiding the precise positioning of the microcatheter tip without interference from the coils. No complications occurred, and successful embolization was achieved in all cases.</p><p><strong>Conclusion: </strong>The sub-marker catheter appears valuable for safely performing aneurysm embolization.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 11","pages":"293-297"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576119/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142683717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ruptured Occipital Artery Aneurysm Following Craniotomy in a Patient with Neurofibromatosis Type 1: Case Report.","authors":"Yuhei Ito, Takao Kojima, Mio Endo, Kiyoshi Saito, Takuya Maeda, Masazumi Fujii","doi":"10.5797/jnet.cr.2023-0098","DOIUrl":"10.5797/jnet.cr.2023-0098","url":null,"abstract":"<p><strong>Objective: </strong>Neurofibromatosis type 1 (NF1) is associated with vascular fragility, which results in aneurysms, arteriovenous fistulas, and dissections. Here, we describe a case of endovascular treatment of a ruptured occipital artery aneurysm that occurred after a craniotomy in a patient with NF1.</p><p><strong>Case presentation: </strong>A 46-year-old man with a history of NF1 underwent a right lateral suboccipital craniotomy to remove a cavernous hemangioma in the right middle cerebellar peduncle. Severe bleeding occurred in the occipital artery during the craniotomy. Due to vessel fragility, coagulation and ligation were not possible, and pressure hemostasis was achieved using cellulose oxide and fibrin glue. On postoperative day 12, the patient developed a sudden swelling on the right side of the neck as well as tracheal compression. Contrast-enhanced CT revealed a ruptured aneurysm in the right occipital artery. Transarterial embolization was performed under general anesthesia the same day. Right external carotid angiography showed an 18-mm-diameter fusiform aneurysm in the occipital artery. The aneurysm ruptured inferiorly to form a large pseudoaneurysm with significant jet flow. An arteriovenous fistula was also observed in a nearby vein. A microcatheter was inserted into the fusiform aneurysm under proximal blood flow control, and embolization was performed using coils and <i>N</i>-butyl-2-cyanoacrylate.</p><p><strong>Conclusion: </strong>Compared to surgical repair of ruptured occipital artery aneurysms, endovascular treatment appears to be safe, effective, minimally invasive, and rapid. Ruptured occipital artery aneurysms in NF1 patients can cause neck swelling and airway compression and should be recognized as a potentially lethal condition.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 6","pages":"177-181"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11189781/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Toshinari Meguro, Yuma Tada, Miki Taniguchi, Shuji Hamauchi, Toru Fukuhara, Yasuyuki Miyoshi, Sigeki Ono
{"title":"Dural Arteriovenous Fistula Treated with Transvenous Embolization via the Upper Limb Cutaneous Vein.","authors":"Toshinari Meguro, Yuma Tada, Miki Taniguchi, Shuji Hamauchi, Toru Fukuhara, Yasuyuki Miyoshi, Sigeki Ono","doi":"10.5797/jnet.tn.2023-0094","DOIUrl":"10.5797/jnet.tn.2023-0094","url":null,"abstract":"<p><strong>Objective: </strong>In recent years, the transradial artery approach has gained prominence and is increasingly employed in neurovascular angiography and therapy due to its safety, reduced complications, and minimal invasiveness. While various venous approaches, including the conventional transfemoral vein approach, exist for procedures such as transvenous embolization, recent reports have highlighted methods involving upper extremity cutaneous veins. However, the practicality and efficacy of these approaches remain unclear.</p><p><strong>Case presentations: </strong>This study presents our experience with three cases of dural arteriovenous fistulas, where transvenous embolization was performed via upper limb cutaneous veins. In all instances, the arteriovenous approach was successfully executed using a single upper extremity, leading to the successful completion of treatment.</p><p><strong>Conclusion: </strong>This technique demonstrates significant advantages, not only in terms of its minimal invasiveness but also due to its simplicity and safety. Anticipating broader acceptance in the future, this approach offers a promising avenue for further exploration in neurovascular interventions.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 5","pages":"142-148"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141163085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}